MENU
RIGL
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Rigel Pharmaceuticals (RIGL) Ownership - Who owns Rigel Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
288.91M
P/E Ratio
N/A
Total Cash
49.1M
Projected Growth
N/A
Total Debt
60.33M
Revenue
130.3M
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
2.79
Total Debt/Equity
N/A
Revenue/Share
7.45 USD as % of share price
Fundamentals
RIGL
Capitalization
289M
P/E Ratio
N/A
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
49.1M
Total Cash/Share
2.79
Total Debt
60.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.45%
Revenue
130M
ROE
N/A
Book Value
-29.91M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
1.62
Current Revenue Per Employee
250619.05
Dividends Per Share - Security
N/A
EBITDA
-4.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.38
Revenue To Assets
-11.59
Shares Held By Institutions
157M
Shares Outstanding - Current
17.6M
Total Liabilities
158M
Total Volume MTD
N/A
Value
-1
Gain YTD
7.793
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com